Oncovin and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oncovin (vincristine sulfate) and Furosemide (furosemide). Common drug interactions include liver disorder among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Oncovin and Furosemide. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.



On Jul, 26, 2026

96 people who take Oncovin and Furosemide together, and have interactions are studied.

Oncovin and Furosemide drug interactions.

What are the common drug interactions of Oncovin and Furosemide, by gender? *:

female:

  1. Liver disorder (liver diseases)
  2. Nausea (feeling of having an urge to vomit)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Oedema (fluid collection in tissue)
  5. Pleural effusion (water on the lungs)
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  8. Folliculitis (infection of hair root)
  9. Hepatic failure (liver failure)
  10. Herpes zoster

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Platelet count decreased
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Pneumonia
  5. Pleural effusion (water on the lungs)
  6. Alanine aminotransferase increased
  7. Diarrhoea
  8. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  9. Interstitial lung disease
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

What are the common drug interactions of Oncovin and Furosemide, by age (0-1 to 60+)? *:

0-1:

  1. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Abdominal pain
  4. Clostridial infection (infectious conditions by clostridium bacteria)
  5. Conjunctivitis (pink eye)
  6. Diarrhoea
  7. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Pain
  10. Penile ulceration

2-9:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Activated partial thromboplastin time prolonged
  3. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  4. Pulmonary congestion (congestion in the lungs)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Renal tubular disorder (disease of kidney tubules)
  7. Septic shock (shock due to blood infection)
  8. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

10-19:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Anaemia (lack of blood)
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Nausea (feeling of having an urge to vomit)
  5. Platelet count decreased
  6. Pyrexia (fever)
  7. White blood cell count decreased
  8. Anaphylactic reaction (serious allergic reaction)
  9. Alanine aminotransferase increased
  10. Bacteraemia (presence of bacteria in the blood)

20-29:

  1. Cystitis haemorrhagic (blood in the urine and painful voiding)
  2. Oedema (fluid collection in tissue)
  3. Precursor b-lymphoblastic lymphoma recurrent (precursor b-cell cancer recurrent)
  4. Pyrexia (fever)
  5. Renal impairment (severely reduced kidney function)
  6. Blood pressure systolic increased
  7. Body temperature increased
  8. Confusional state
  9. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  10. Dry skin

30-39:

  1. Anaemia (lack of blood)
  2. Hepatic steatosis (fatty liver disease)
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Alanine aminotransferase increased
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Cardiac failure
  8. Constipation
  9. Diarrhoea
  10. Disseminated intravascular coagulation (systemic activation of blood coagulation)

40-49:

  1. Anaemia (lack of blood)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Cardiac failure
  4. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  5. Cystitis haemorrhagic (blood in the urine and painful voiding)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Herpes zoster
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Platelet count decreased
  10. Pulmonary oedema (fluid accumulation in the lungs)

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. White blood cell count decreased
  3. Anaemia (lack of blood)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Oedema (fluid collection in tissue)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Alanine aminotransferase increased
  8. Cardiac failure
  9. Mallory-weiss syndrome (gastro-oesophageal laceration syndrome refers to bleeding from tears)
  10. Pneumonia

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Platelet count decreased
  3. Septic shock (shock due to blood infection)
  4. Anaemia (lack of blood)
  5. Arteritis (inflammation of the walls of arteries)
  6. Myelosuppression (a decrease in the production of blood cells)
  7. Nausea (feeling of having an urge to vomit)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Pneumonia
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. High Blood Pressure: 18 people, 18.75%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 16 people, 16.67%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 15 people, 15.62%
  4. Insomnia (sleeplessness): 11 people, 11.46%
  5. Lymphoma (cancer that begins in immune system cells): 10 people, 10.42%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 10 people, 10.42%
  7. Fever: 8 people, 8.33%
  8. Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 6 people, 6.25%
  9. Constipation: 6 people, 6.25%
  10. Urinary Tract Infection: 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oncovin and Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oncovin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oncovin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate and furosemide (the active ingredients of Oncovin and Furosemide, respectively), and Oncovin and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: